日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Final analysis of nivolumab plus cabozantinib for advanced renal cell carcinoma from the randomized phase III CheckMate 9ER trial

CheckMate 9ER 随机 III 期试验中,对纳武利尤单抗联合卡博替尼治疗晚期肾细胞癌的最终分析

Motzer, R J; Escudier, B; Burotto, M; Powles, T; Apolo, A B; Bourlon, M T; Shah, A Y; Porta, C; Suárez, C; Barrios, C H; Richardet, M; Gurney, H; Kessler, E R; Tomita, Y; Bedke, J; Scheffold, C; Askelson, M; Panzica, J; Zhang, J; van Kooten Losio, M; Choueiri, T K

Simlukafusp alfa (FAP-IL2v) plus atezolizumab with or without bevacizumab in unresectable, metastatic renal cell carcinoma: a randomized, open-label phase Ib study

Simlukafusp alfa (FAP-IL2v) 联合阿特珠单抗,加或不加贝伐珠单抗,用于治疗不可切除的转移性肾细胞癌:一项随机、开放标签的 Ib 期研究

Perez-Gracia, Jose Luis; Mellado, Begoña; Hansen, Aaron Richard; Alonso-Gordoa, Teresa; Gomez-Roca, Carlos; Løvendahl Eefsen, Rikke; Negrier, Sylvie; Suárez, Cristina; Lee, Jae-Lyun; Hussain, Arif; Pedrazzoli, Paolo; Moreno, Victor; Rodriguez-Vida, Alejo; Sosman, Jeffrey Alan; Waddell, Tom; Bedke, Jens; Park, Se Hoon; Sznol, Mario; Spychaj, Lukasz; Andersson, Emilia; Julien-Laferriere, Alice; Cheng, Wei-Yi; Watson, Carl; Silva, Ana Patricia; Heichinger, Christian; Staedler, Nicolas; Sleiman, Nassim; Dejardin, David; Boetsch, Christophe; Evers, Stefan; Vardar, Taner; Ardeshir-Tandon, Caroline; Dorado Pérez, Jorge; Charo, Jehad; Keshelava, Nino; Kraxner, Anton; Teichgräber, Volker; Powles, Thomas

Pan-Asian subgroup analysis of EV-302/KEYNOTE-A39: a phase 3 study to evaluate enfortumab vedotin and pembrolizumab in patients with untreated advanced urothelial carcinoma

EV-302/KEYNOTE-A39 泛亚洲亚组分析:一项评估恩福妥单抗和帕博利珠单抗治疗未经治疗的晚期尿路上皮癌患者的 3 期研究

Kikuchi, Eiji; Van der Heijden, Michiel S; Valderrama, Begoña P; Gupta, Shilpa; Bedke, Jens; Shin, Sang Joon; Li, Jian-Ri; Guo, Jun; Danchaivijitr, Pongwut; Kanesvaran, Ravindran; Park, Se Hoon; Su, Wen-Pin; Kandori, Shuya; Bae, Woo Kyun; Wong, Alvin; Gorla, Seema; Bavle, Abhishek; Yu, Xuesong; Lu, Yi-Tsung; Powles, Thomas

How enfortumab vedotin plus pembrolizumab affects the quality of life of people with advanced urothelial cancer compared with platinum-based chemotherapy: a plain language summary of patient-reported outcomes from the EV-302 study

与铂类化疗相比,恩福妥单抗联合帕博利珠单抗治疗对晚期尿路上皮癌患者生活质量的影响:EV-302 研究患者报告结局的简明语言总结

Gupta, Shilpa; Loriot, Yohann; Van der Heijden, Michiel S; Bedke, Jens; Valderrama, Begoña P; Kikuchi, Eiji; Fléchon, Aude; Petrylak, Daniel; De Santis, Maria; Galsky, Matthew D; Lee, Jae Lyun; Swami, Umang; Sridhar, Srikala S; De Giorgi, Ugo; Wright, Phoebe; Shih, Vanessa; Lu, Yi-Tsung; Guan, Xuesong; Dillon, Ryan; Shetty, Aditya; Homet Moreno, Blanca; Beaumont, Jennifer L; Purnajo, Intan; McManus, Shauna; Powles, Thomas

Nivolumab plus gemcitabine-cisplatin for unresectable or metastatic urothelial carcinoma: health-related quality-of-life analyses from the phase III CheckMate 901 trial

纳武利尤单抗联合吉西他滨-顺铂治疗不可切除或转移性尿路上皮癌:来自 III 期 CheckMate 901 试验的健康相关生活质量分析

Bedke, J; van der Heijden, M S; Sonpavde, G; Galsky, M D; Liao, W; Shi, L; Blum, S I; Mitra, S; Patel, M Y; Powles, T

Health-related quality-of-life profile and clinical outcomes in first-line advanced renal cell carcinoma: a modeling analysis based on the CheckMate 9ER study

一线晚期肾细胞癌患者的健康相关生活质量状况和临床结局:基于CheckMate 9ER研究的建模分析

Cella, D; Derosa, M; Floden, L; Giles, R H; Lothgren, M; Ogareva, A; Powles, T; Purnajo, I; Choueiri, T K; Bergerot, C; Motzer, R J; Bedke, J

Exploratory subgroup analyses of EV-302: a phase III global study to evaluate enfortumab vedotin in combination with pembrolizumab versus chemotherapy in previously untreated locally advanced or metastatic urothelial carcinoma

EV-302 的探索性亚组分析:一项评估恩福妥单抗联合帕博利珠单抗与化疗治疗既往未接受治疗的局部晚期或转移性尿路上皮癌的 III 期全球研究

van der Heijden, M S; Powles, T; Gupta, S; Loriot, Y; Galsky, M D; Valderrama, B P; Sridhar, S S; Yu, E Y; Iyer, G; Kikuchi, E; Castellano, D; Hoffman-Censits, J; Drakaki, A; Mar, N; Maroto Rey, J P; Vulsteke, C; Arafat, W; Duran, I; Dawson, N A; Swami, U; Gorla, S; Moreno, B H; Yu, X; Lu, Y-T; Bedke, J

Treatment of advanced urothelial cancer with nivolumab plus chemotherapy versus chemotherapy alone (CheckMate 901 study): a plain language summary

纳武利尤单抗联合化疗与单纯化疗治疗晚期尿路上皮癌的疗效比较(CheckMate 901 研究):简明扼要的总结

van der Heijden, Michiel S; Sonpavde, Guru; Powles, Thomas; Necchi, Andrea; Burotto, Mauricio; Schenker, Michael; Sade, Juan Pablo; Bamias, Aristotelis; Beuzeboc, Philippe; Bedke, Jens; Oldenburg, Jan; Chatta, Gurkamal; Ürün, Yüksel; Ye, Dingwei; He, Zhisong; Valderrama, Begoña P; Ku, Ja Hyeon; Tomita, Yoshihiko; Filian, Jeiry; Wang, Lily; Purcea, Daniela; Patel, Miraj Y; Nasroulah, Federico; Galsky, Matthew D

Collagen fleece grafting for surgical treatment of patients with mild to severe peyronie's curvatures

胶原蛋白绒毛移植术用于治疗轻度至重度阴茎弯曲症患者

Garaz, Radion; Amend, Bastian; Stenzl, Arnulf; Bedke, Jens; Hennenlotter, Jörg; Rochwarger, Alexander; Schürch, Christian M; Tsaur, Igor; Rausch, Steffen

PS-15 Effects of source and level of ruminal undegradable protein on serum glucose, insulin, and urea nitrogen in developing beef heifers fed in a dry-lot

PS-15 瘤胃不可降解蛋白的来源和水平对干栏饲养的肉牛犊血清葡萄糖、胰岛素和尿素氮的影响

Rosol, Thomas J; Tannehill-Gregg, Sarah H; Corn, Stephanie; Schneider, Abraham; McCauley, Laurie K; Andrews, Taylor N; Christianson, Aria; Snider, Alexandria P; Cushman, Robert A; Bedke, Clayton; Richardson, Katylyn; Cooper, Joyce Anne; Perry, George A; Summers, Adam F; Scholljegerdes, Eric J; Andrews, Taylor N; Henington, Ashton; Bedke, Clayton; Cooper, Joyce Anne; Richardson, Katylyn; Cushman, Robert A; Snider, Alexandria P; Fontes, Pedro; Smith, Molly Sloan; Summers, Adam F; Scholljegerdes, Eric J